Research News
View articles by month and year
-
Calcium and Vitamin D Supplements Don’t Reduce Risk in Postmenopausal Women
Results from the Women's Health Initiative study suggest that vitamin D and calcium supplements don't lower breast cancer risk.
-
Can Migraine Cause Protect Against Breast Cancer?
Women who get migraine headaches appear to have a lower risk of breast cancer compared to women who don't get migraines.
-
After Menopause, Women May Lower Risk with Strenuous Exercise
Vigorous exercise may lower the risk of breast cancer in post-menopausal women.
-
Lab Study Suggests Second-Hand Smoke Ups Risk
Exposure to nicotine from cigarettes you smoke as well from second-hand smoke from other people's cigarettes seems to make breast cancer cells grow and spread.
-
No Link Between Coffee and Risk
A new study provides more evidence that there seems to be no link between caffeine and breast cancer risk.
-
Genetic Test Results Can Offer Peace of Mind
Women at high risk for breast cancer who had genetic testing benefited psychologically from knowing the results of the test.
-
Bigger Babies May Have Higher Breast Cancer Risk
Researchers have found an association between birth size and the risk of breast cancer later in life.
-
Hormone Replacement Therapy Doesn’t Seem to Increase Risk in Women with Abnormal BRCA1 Gene
A small study suggests that combination hormone replacement therapy doesn't seem to raise the risk of breast cancer in post-menopausal women with an abnormal BRCA1 gene, but several leading researchers don't think the results are definitive.
-
Breast Cancer Gene Prediction Models Not Accurate for Asian Women
Two models used to predict BRCA1 and BRCA2 gene abnormalities aren't very accurate when used on Asian women.
-
Removing Opposite, Healthy Breast Reduces Risk of New Cancer
Contralateral prophylactic mastectomy -- removing the opposite healthy breast -- reduced the risk of developing a new breast cancer in the other breast and also reduced the risk of dying from breast cancer by about 30% for young women diagnosed with early-stage, hormone-receptor-negative breast cancer.
